The most important target cell of SARS-CoV-2 is Type II pneumocyte which produces and secretes pulmonary surfactant (PS) that prevents alveolar collapse. PS instillation therapy is dramatically effect for infant respiratory distress syndrome but has been clinically ineffective for ARDS. |